These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 8319355
1. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355 [Abstract] [Full Text] [Related]
2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898 [Abstract] [Full Text] [Related]
3. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO. Circulation; 1995 Aug 01; 92(3):320-6. PubMed ID: 7634444 [Abstract] [Full Text] [Related]
4. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. Nishikawa Y, Ogawa S. J Am Coll Cardiol; 1997 Jan 01; 29(1):85-92. PubMed ID: 8996299 [Abstract] [Full Text] [Related]
5. Nitric oxide activity in the atherosclerotic human coronary circulation. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO. J Am Coll Cardiol; 1997 Feb 01; 29(2):308-17. PubMed ID: 9014982 [Abstract] [Full Text] [Related]
6. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Circulation; 1994 Dec 01; 90(6):2853-8. PubMed ID: 7994830 [Abstract] [Full Text] [Related]
7. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO. J Clin Invest; 1995 Apr 01; 95(4):1747-55. PubMed ID: 7706483 [Abstract] [Full Text] [Related]
8. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis. Gurevicius J, Salem MR, Metwally AA, Silver JM, Crystal GJ. Am J Physiol; 1995 Jan 01; 268(1 Pt 2):H39-47. PubMed ID: 7530920 [Abstract] [Full Text] [Related]
9. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Canty JM, Schwartz JS. Circulation; 1994 Jan 01; 89(1):375-84. PubMed ID: 8281673 [Abstract] [Full Text] [Related]
10. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis. Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G. Heart; 1997 Nov 01; 78(5):493-8. PubMed ID: 9415011 [Abstract] [Full Text] [Related]
11. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. Chu A, Chambers DE, Lin CC, Kuehl WD, Palmer RM, Moncada S, Cobb FR. J Clin Invest; 1991 Jun 01; 87(6):1964-8. PubMed ID: 2040689 [Abstract] [Full Text] [Related]
12. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans. Joannides R, Richard V, Haefeli WE, Linder L, Lüscher TF, Thuillez C. Hypertension; 1995 Aug 01; 26(2):327-31. PubMed ID: 7635543 [Abstract] [Full Text] [Related]
13. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. Tagawa T, Mohri M, Tagawa H, Egashira K, Shimokawa H, Kuga T, Hirooka Y, Takeshita A. J Cardiovasc Pharmacol; 1997 Apr 01; 29(4):546-53. PubMed ID: 9156366 [Abstract] [Full Text] [Related]
14. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries. Tousoulis D, Tentolouris C, Crake T, Toutouzas P, Davies G. J Am Coll Cardiol; 1997 May 01; 29(6):1256-62. PubMed ID: 9137221 [Abstract] [Full Text] [Related]
15. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G. Am Heart J; 1996 Jun 01; 131(6):1051-7. PubMed ID: 8644581 [Abstract] [Full Text] [Related]
16. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A. Circ Res; 1996 Aug 01; 79(2):331-5. PubMed ID: 8756012 [Abstract] [Full Text] [Related]
17. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation. Miner SE, Al-Hesayen A, Nield LE, Gori T, Parker JD. Exp Physiol; 2010 Dec 01; 95(12):1167-76. PubMed ID: 20817701 [Abstract] [Full Text] [Related]
18. Magnesium causes nitric oxide independent coronary artery vasodilation in humans. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. Heart; 2001 Aug 01; 86(2):212-6. PubMed ID: 11454846 [Abstract] [Full Text] [Related]
19. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Dubois-Randé JL, Zelinsky R, Roudot F, Chabrier PE, Castaigne A, Geschwind H, Adnot S. Am J Cardiol; 1992 Nov 15; 70(15):1269-75. PubMed ID: 1442577 [Abstract] [Full Text] [Related]
20. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Hypertension; 1997 Jan 15; 29(1 Pt 2):274-9. PubMed ID: 9039114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]